Jana Maláková

724 total citations
40 papers, 573 citations indexed

About

Jana Maláková is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Pharmacology. According to data from OpenAlex, Jana Maláková has authored 40 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pediatrics, Perinatology and Child Health, 11 papers in Oncology and 9 papers in Pharmacology. Recurrent topics in Jana Maláková's work include Pharmacological Effects and Toxicity Studies (12 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Jana Maláková is often cited by papers focused on Pharmacological Effects and Toxicity Studies (12 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Jana Maláková collaborates with scholars based in Czechia, Slovakia and Serbia. Jana Maláková's co-authors include Vladimír Palička, J Simko, Petr Pávek, Jan Kremláček, František Štaud, Z. Fendrich, Pavel Živný, Lukáš Červený, Hana Brozmanová and Sylva Skálová and has published in prestigious journals such as Molecules, European Journal of Pharmacology and Journal of Pharmaceutical Sciences.

In The Last Decade

Jana Maláková

38 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jana Maláková Czechia 13 191 154 99 63 61 40 573
Natalia Borg Sweden 11 143 0.7× 154 1.0× 147 1.5× 22 0.3× 91 1.5× 22 733
Junko Ishizaki Japan 18 132 0.7× 278 1.8× 81 0.8× 77 1.2× 110 1.8× 61 931
Ulrike Ebert Germany 11 118 0.6× 146 0.9× 53 0.5× 59 0.9× 74 1.2× 20 532
Maryam Mehrpooya Iran 16 40 0.2× 92 0.6× 59 0.6× 42 0.7× 34 0.6× 70 677
Giovanna Cipolla Italy 13 159 0.8× 59 0.4× 176 1.8× 55 0.9× 67 1.1× 19 541
Razieh Mohammad Jafari Iran 18 73 0.4× 41 0.3× 84 0.8× 65 1.0× 78 1.3× 77 796
Ryan Z. Turncliff United States 18 232 1.2× 361 2.3× 191 1.9× 121 1.9× 181 3.0× 24 1.1k
Catharina Scholl Germany 15 54 0.3× 111 0.7× 38 0.4× 41 0.7× 45 0.7× 47 832
J.F. Horga Spain 17 88 0.5× 63 0.4× 60 0.6× 92 1.5× 85 1.4× 47 729
Engin Yıldırım Türkiye 16 64 0.3× 112 0.7× 18 0.2× 48 0.8× 51 0.8× 69 762

Countries citing papers authored by Jana Maláková

Since Specialization
Citations

This map shows the geographic impact of Jana Maláková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Maláková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Maláková more than expected).

Fields of papers citing papers by Jana Maláková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jana Maláková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Maláková. The network helps show where Jana Maláková may publish in the future.

Co-authorship network of co-authors of Jana Maláková

This figure shows the co-authorship network connecting the top 25 collaborators of Jana Maláková. A scholar is included among the top collaborators of Jana Maláková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana Maláková. Jana Maláková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Žák, Pavel, Jakub Radocha, Benjamín Víšek, et al.. (2025). Population Pharmacokinetic Model‐Based Optimization of Linezolid Dosing in Hematooncological Patients With Suspected or Proven Gram‐Positive Sepsis. Clinical and Translational Science. 18(9). e70346–e70346.
2.
Štěpán, Martin, et al.. (2023). Dynamics of the vitamin D C3-epimer levels in preterm infants. Clinical Chemistry and Laboratory Medicine (CCLM). 61(6). 1084–1094. 4 indexed citations
3.
4.
Šíma, Martin, Jana Maláková, Pavel Žák, et al.. (2022). Superiority of ceftazidime off‐label high‐dose regimen in PK/PD target attainment during treatment of extensively drug‐resistant Pseudomonas aeruginosa infections in cancer patients. British Journal of Clinical Pharmacology. 89(4). 1452–1461. 4 indexed citations
5.
Maláková, Jana, et al.. (2020). Lung Collapse during Mini-Thoracotomy Reduces Penetration of Cefuroxime to the Tissue: Interstitial Microdialysis Study in Animal Models. Surgical Infections. 22(3). 283–291. 1 indexed citations
6.
Kubeček, Ondřej, Jiřina Martı́nková, Jaroslav Chládek, et al.. (2019). Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resistant ovarian cancer. Cancer Chemotherapy and Pharmacology. 85(2). 353–365. 4 indexed citations
7.
Simko, J, et al.. (2019). The effect of gabapentin and pregabalin on bone turnover and bone strength: A prospective study in Wistar rats. Pharmacological Reports. 71(6). 1213–1218. 4 indexed citations
8.
Buchta, Vladimı́r, et al.. (2019). Is it possible to shorten serum bactericidal testing?. Journal of Microbiological Methods. 168. 105775–105775. 1 indexed citations
9.
Voglová, J, Zdeněk Ráčil, Daniela Žáčková, et al.. (2018). The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients. Archives of Medical Science. 14(6). 1416–1423. 14 indexed citations
10.
Kučera, Tomáš, Tomáš Soukup, Jana Maláková, et al.. (2017). Elution kinetics of vancomycin and gentamicin from carriers and their effects on mesenchymal stem cell proliferation: an in vitro study. BMC Musculoskeletal Disorders. 18(1). 381–381. 12 indexed citations
11.
12.
Simko, J, et al.. (2014). The effect of topiramate and lamotrigine on rat bone mass, structure and metabolism. Journal of the Neurological Sciences. 340(1-2). 80–85. 12 indexed citations
13.
Simko, J, Jana Maláková, Jan Kremláček, et al.. (2014). The effect of lacosamide on bone tissue in orchidectomised male albino Wistar rats. Biomedical Papers. 159(3). 394–399. 9 indexed citations
14.
Simko, J, et al.. (2013). The effect of levetiracetam on rat bone mass, structure and metabolism. Epilepsy Research. 107(1-2). 56–60. 27 indexed citations
15.
Fuksa, Leoš, Eva Brčáková, Jolana Cermanová, et al.. (2008). Amiodarone modulates pharmacokinetics of low‐dose methotrexate in rats. Biopharmaceutics & Drug Disposition. 29(5). 289–299. 8 indexed citations
16.
Manďák, Jiří, et al.. (2008). TISSUE AND PLASMA CONCENTRATIONS OF ANTIBIOTIC DURING CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS - MICRODIALYSIS STUDY. Biomedical Papers. 152(1). 139–145. 11 indexed citations
17.
Adamcová, Michaela, Tomáš Šimůnek, Helena Mertlíková‐Kaiserová, et al.. (2007). In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity. Toxicology. 237(1-3). 218–228. 50 indexed citations
18.
Maláková, Jana, et al.. (2007). A Capillary GC Method Using Nitrogen Phosphorus Detection for Determination of Topiramate in Patients with Epilepsy. Chromatographia. 66(5-6). 363–367. 14 indexed citations
19.
Pávek, Petr, Z. Fendrich, František Štaud, et al.. (2001). Influence of P‐Glycoprotein on the Transplacental Passage of Cyclosporine. Journal of Pharmaceutical Sciences. 90(10). 1583–1592. 55 indexed citations
20.
Maláková, Jana, et al.. (1999). Pharmacokinetics of netilmicin in neonates. Medical Science Monitor. 5(2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalia Borg Breakdown of academic impact, for papers by Junko Ishizaki Breakdown of academic impact, for papers by Ulrike Ebert Breakdown of academic impact, for papers by Maryam Mehrpooya Breakdown of academic impact, for papers by Giovanna Cipolla Breakdown of academic impact, for papers by Razieh Mohammad Jafari Breakdown of academic impact, for papers by Ryan Z. Turncliff Breakdown of academic impact, for papers by Catharina Scholl Breakdown of academic impact, for papers by J.F. Horga Breakdown of academic impact, for papers by Engin Yıldırım
Rankless by CCL
2026